Cogent Biosciences, Inc.
COGTPharmaceutical Preparations · SIC 2834 · CIK 0001622229
Revenue FY2025
—
Net Income
$(329.0M)
EPS (Basic)
$-2.16
Net Margin
—
ROE
-51.7%
Total Equity
$636.0M
Shares Out
174M
Cogent Biosciences, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2017–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 6 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Platinum Investment Management
Platinum Investment Management
$6.0M
1.5%
+37.6%
Deerfield Management Company
Deerfield Management Company
$193.7M
1.0%
(44.6%)
OrbiMed Advisors
OrbiMed Advisors
$65.1M
0.3%
+422.0%
Renaissance Technologies
Renaissance Technologies
$38.6M
0.0%
+41.0%
Adage Capital Management
Adage Capital Management
$1.9M
0.0%
—
Holocene Advisors
Holocene Advisors
$1.3M
0.0%
(98.5%)
Insider Transactions
Reading stored insider transactions…